Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679363-24-000046
Filing Date
2024-07-25
Accepted
2024-07-25 07:05:59
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q morf-20240630.htm   iXBRL 10-Q 1346916
2 EX-31.1 morf-2024630x10qex311.htm EX-31.1 10304
3 EX-31.2 morf-2024630x10qex312.htm EX-31.2 10300
4 EX-32.1 morf-2024630x10qex321.htm EX-32.1 4684
5 EX-32.2 morf-2024630x10qex322.htm EX-32.2 4709
  Complete submission text file 0001679363-24-000046.txt   5381316

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT morf-20240630.xsd EX-101.SCH 28465
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT morf-20240630_cal.xml EX-101.CAL 46210
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT morf-20240630_def.xml EX-101.DEF 172376
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT morf-20240630_lab.xml EX-101.LAB 468653
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT morf-20240630_pre.xml EX-101.PRE 327548
64 EXTRACTED XBRL INSTANCE DOCUMENT morf-20240630_htm.xml XML 560606
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 (781) 996-0955
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

EIN.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38940 | Film No.: 241139770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)